ESTRO35 Programme Book

> PSA kinetics following SBRT versus conventionally fractionated EBRT for localised prostate cancer H. Kim (Republic of Korea), J.H. Phark, W.C. Kim > Prostate cancer hypofractionation: impact of prostate gland dimension in genitourinary toxicity S. Fersino (Italy), N. Giaj Levra, R. Mazzola, A. Fiorentino, F. Ricchetti, R. Ruggieri, F. Alongi

EP-1334

ELECTRONIC POSTERS

EP-1335

> Hypofractionated salvage radiotherapy after radical prostatectomy P. Bulychkin (Russian Federation), S. Tkachev, A. Mikhailova

EP-1336

> PSA Kinetics: HDR Prostate Brachytherapy boost in combination with external beam radiotherapy S. Rodda (UK), F. Sun, A. Henry, K. Franks, D. Bottomley > Delay Haematuria after prostatic radiotherapy: do it mean always radiation cystitis? S. Rodríguez Villalba (Spain), M. Santos Ortega, M. Depiaggio, A. Fuster, P. Torrus, J. Martinez, J. Canovas, L. De la Torre, J. Moreno, J. Richart, A. Otal, J. Perez Calatayud > Influence of leaf thickness on prostate VMAT about dosimeto- volumetoric and delivering parameters H. Nagano (Japan), H. Yokoyama, H. Hashimoto, M. Watanabe, M. Nakanishi, Y. Kishida, T. Ogawa, T. Kawasaki, M. Katou, T. Shimo, K. Ishizuka > Nomograms predicting the probabilities of having indications for adjuvant prostatic radiotherapy M. Ma (China), X. Gao, Z. Zhou, B. Zhao > Single-nucleotide polymorphisms associated with toxicity to radiotherapy in prostate cancer patients G. Spagnoletti (Italy), P. Frisani, M. Natalicchio, M. Enfasi, G. Cocco, G. Nardella, G. Plotino, G. Bove > F-18Fluorcholine-PET/CT guide salvage therapy in biochemical failure of prostate cancer M. Barrado (Spain), A. Sola, P. Navarrete, E. Villafranca, M. Rico, M. Errasti, M. Campo, I. Visus, S. Flamarique, M. Rodríguez, E. Martínez EP-1342 EP-1339 EP-1341 EP-1337 EP-1338 EP-1340

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

246